0.6596
Schlusskurs vom Vortag:
$0.5822
Offen:
$0.5569
24-Stunden-Volumen:
2.04M
Relative Volume:
0.34
Marktkapitalisierung:
$29.37M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-3.298
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
+21.45%
1M Leistung:
+56.82%
6M Leistung:
+90.69%
1J Leistung:
-71.20%
Harvard Bioscience Inc Stock (HBIO) Company Profile
Firmenname
Harvard Bioscience Inc
Sektor
Telefon
(508) 893-8999
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Vergleichen Sie HBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
HBIO
Harvard Bioscience Inc
|
0.6596 | 25.95M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Eingeleitet | Northland Capital | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Herabstufung | Janney | Buy → Neutral |
| 2018-01-24 | Bestätigt | Janney | Buy |
| 2018-01-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-11-17 | Eingeleitet | Singular Research | Buy |
| 2015-07-28 | Eingeleitet | The Benchmark Company | Buy |
Alle ansehen
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
How Harvard Bioscience Inc. stock trades before earningsJuly 2025 Outlook & High Accuracy Trade Alerts - newser.com
Is Harvard Bioscience Inc. (HBI) stock cheap vs fundamentals2025 Dividend Review & Real-Time Volume Analysis Alerts - newser.com
Published on: 2025-11-14 18:26:15 - newser.com
Can Harvard Bioscience Inc. stock hit analyst price targets2025 Investor Takeaways & Daily Price Action Insights - newser.com
Can Harvard Bioscience Inc. (HBI) stock stage a strong rebound this quarterJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com
Is Harvard Bioscience Inc. stock a buy before product launchesJuly 2025 Gainers & Long-Term Safe Investment Ideas - newser.com
Will Harvard Bioscience Inc. stock benefit from sector rotationJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
Key resistance and support levels for Harvard Bioscience Inc.Quarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Analyzing Harvard Bioscience Inc. with risk reward ratio charts2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
Will Harvard Bioscience Inc. stock gain from strong economy - newser.com
Will Harvard Bioscience Inc. (HBI) stock benefit from mergersQuarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
Published on: 2025-11-12 14:30:59 - newser.com
Harvard Bioscience (HBIO) Stock Price Quote Today & Current Price Chart - Capital.com
Is Harvard Bioscience Inc. stock a contrarian buyWeekly Investment Summary & Free Long-Term Investment Growth Plans - newser.com
Harvard Bioscience’s Earnings Call: Optimism Amid Challenges - MSN
Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Shares Bounce 29% But Its Business Still Trails The Industry - 富途牛牛
Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest Report - Yahoo Finance
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Stock: A Contradiction of Weak Earnings and Financial Improvement - AD HOC NEWS
Harvard Bioscience targets $22.5M–$24.5M Q4 revenue as backlog reaches two-year high, expanding product rollouts and distribution - MSN
Harvard Bioscience, Inc. (HBIO) Stock forecasts - Yahoo Finance UK
Is It Time To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance
Harvard Bioscience Inc (HBIO) Q3 2025 Earnings Call Highlights: Strong Margins and Strategic ... By GuruFocus - Investing.com Canada
Harvard Bioscience: Q3 Earnings Snapshot - CT Insider
Harvard Bioscience Reports Q3 2025 Financial Results - TipRanks
Harvard Bioscience, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:HBIO) 2025-11-07 - Seeking Alpha
Transcript : Harvard Bioscience, Inc., Q3 2025 Earnings Call, Nov 06, 2025 - MarketScreener
Applying Wyckoff theory to Harvard Bioscience Inc. stockPortfolio Return Report & Detailed Earnings Play Alerts - newser.com
[10-Q] HARVARD BIOSCIENCE INC Quarterly Earnings Report | HBIO SEC FilingForm 10-Q - Stock Titan
Earnings call transcript: Harvard Bioscience Q3 2025 misses EPS forecast By Investing.com - Investing.com Nigeria
Harvard Bioscience Inc (HBIO) Q3 2025 Earnings Call Highlights: - GuruFocus
Harvard Bioscience Cuts Losses As Revenue Beats Forecasts - Finimize
Harvard Bioscience Inc (HBIO) Q3 2025 Earnings Call Highlights: Strong Margins and Strategic ... - Yahoo Finance
Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):